Etravirine in CSF is highly protein bound (Q36762988)

16 August 2017

Etravirine in CSF is highly protein bound (English)

1 reference

16 August 2017

Ronald J Ellis

13

0 references

Igor Grant

14

object named as

Igor Grant

1 reference

16 August 2017

16

Scott Letendre

1 reference

16 August 2017

11

Susan Morgello

1 reference

16 August 2017

17

CHARTER Group

1 reference

16 August 2017

10

J Allen McCutchan

1 reference

16 August 2017

8

Christina Marra

1 reference

16 August 2017

7

Benjamin Gelman

1 reference

16 August 2017

9

Justin McArthur

1 reference

16 August 2017

4

Brookie M Best

1 reference

16 August 2017

3

David Croteau

1 reference

16 August 2017

15

Edmund Capparelli

1 reference

16 August 2017

6

Ann C Collier

1 reference

16 August 2017

Anh Nguyen

1

1 reference

16 August 2017

Steven Rossi

2

1 reference

16 August 2017

David Clifford

5

1 reference

16 August 2017

David Simpson

12

1 reference

16 August 2017

language of work or name

English

0 references

publication date

20 January 2013

1 reference

Journal of Antimicrobial Chemotherapy

16 August 2017

1 reference

16 August 2017

68

1 reference

16 August 2017

5

1 reference

16 August 2017

1161-1168

1 reference

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Lopinavir protein binding in HIV-1-infected pregnant women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Protein binding in antiretroviral therapies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Comparison of the Beckman TL-100 ultracentrifuge with the Amicon Centrifree Micropartition filters to determine protein-free phenytoin concentrations.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Etravirine concentrations in CSF in HIV-infected patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Efficacy of etravirine for treatment of acute HIV meningoencephalitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625433

5 September 2018

Identifiers

DOI

10.1093/JAC/DKS517

1 reference

16 August 2017

1 reference

16 August 2017

1 reference